Wed, January 8, 2020

Hartaj Singh Maintained (VRTX) at Buy with Increased Target to $265 on, Jan 8th, 2020

Hartaj Singh of Oppenheimer, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $230 to $265 on, Jan 8th, 2020.

Hartaj has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 0 agree with Hartaj's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Hartaj


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
  • Ying Huang of "B of A Securities" Reiterated at Strong Buy with Increased Target to $245 on, Wednesday, November 20th, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $250 on, Thursday, October 31st, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $229 on, Thursday, October 31st, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019